Dong-A Socio Holdings Co Ltd (000640) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd., offers business management services. It is a subsidiary of Dong-A Socio Group. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group focuses on new business investments, development of biomedicines and research and development of new innovative drugs. Its main business areas include the manufacture of over-the-counter (OTC) and ethical drugs (ETC). Its major products include Bacchus-F, Bacchus-D, Panpyrin, Benachio, Myvlart Tab, Tempo and Eyebon. It also manufactures active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Dong-A Socio Holdings is headquartered in Seoul, South Korea.

Dong-A Socio Holdings Co Ltd (000640) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Dong-A ST Extends Licensing Agreement with Eurofarma 11
Kaken Pharma Enters into Distribution Agreement with Dong-A ST 12
CrystalGenomics Enters into Agreement with Dong-A ST for Acelex 13
Dong-A ST Enters Into Co-Marketing Agreement With Huons For Nenoma 14
Licensing Agreements 15
Neurobo Pharma Enters into Licensing Agreement with Dong-A ST 15
Rooyan Darou Pharma Enters into Agreement with Dong-A ST 16
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 17
AbbVie Enters into Licensing Agreement with Dong-A ST 18
Dong-A ST Enters into Licensing Agreement with Beactica 19
ST Pharm Enters into Technology Transfer Agreement with KRICT 20
Tobira Therapeutics Enters into Licensing Agreement with Dong-A for Evogliptin 21
Dong-A Enters into Licensing Agreement with Tobira Therapeutics for Cenicriviroc 23
Geropharm Enters into Licensing Agreement with Dong-A ST 24
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 25
Dong-A Pharma Enters Into Licensing Agreement With Alkem Labs For DA-1229 26
Sanwa Kagaku Kenkyusho Enters into Licensing Agreement with Dong-A ST 27
Luye Pharma Group Enters Into Licensing Agreement With Dong-A Pharma For DA-1229 28
Equity Offering 29
ST Pharm to Raise USD113 Million in IPO 29
Dong-A Pharma Spin-Off Dong-A ST 30
Acquisition 31
Dong-A Socio to Acquire Shares of ST Pharm for USD157 Million in Tender Offer 31
Dong-A Socio to Divest Stake in DMB 32
Dong-A Pharmaceutical Mulling Acquisition of Spains Invent Farma 33
Dong-A Socio Holdings Co Ltd - Key Competitors 34
Dong-A Socio Holdings Co Ltd - Key Employees 35
Dong-A Socio Holdings Co Ltd - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List Of Tables


Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dong-A Socio Holdings Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dong-A ST Extends Licensing Agreement with Eurofarma 11
Kaken Pharma Enters into Distribution Agreement with Dong-A ST 12
CrystalGenomics Enters into Agreement with Dong-A ST for Acelex 13
Dong-A ST Enters Into Co-Marketing Agreement With Huons For Nenoma 14
Neurobo Pharma Enters into Licensing Agreement with Dong-A ST 15
Rooyan Darou Pharma Enters into Agreement with Dong-A ST 16
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 17
AbbVie Enters into Licensing Agreement with Dong-A ST 18
Dong-A ST Enters into Licensing Agreement with Beactica 19
ST Pharm Enters into Technology Transfer Agreement with KRICT 20
Tobira Therapeutics Enters into Licensing Agreement with Dong-A for Evogliptin 21
Dong-A Enters into Licensing Agreement with Tobira Therapeutics for Cenicriviroc 23
Geropharm Enters into Licensing Agreement with Dong-A ST 24
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 25
Dong-A Pharma Enters Into Licensing Agreement With Alkem Labs For DA-1229 26
Sanwa Kagaku Kenkyusho Enters into Licensing Agreement with Dong-A ST 27
Luye Pharma Group Enters Into Licensing Agreement With Dong-A Pharma For DA-1229 28
ST Pharm to Raise USD113 Million in IPO 29
Dong-A Pharma Spin-Off Dong-A ST 30
Dong-A Socio to Acquire Shares of ST Pharm for USD157 Million in Tender Offer 31
Dong-A Socio to Divest Stake in DMB 32
Dong-A Pharmaceutical Mulling Acquisition of Spains Invent Farma 33
Dong-A Socio Holdings Co Ltd, Key Competitors 34
Dong-A Socio Holdings Co Ltd, Key Employees 35
Dong-A Socio Holdings Co Ltd, Subsidiaries 36
Dong-A Socio Holdings Co Ltd, Joint Venture 37

List Of Figures


Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Dong-A Socio Holdings Co Ltd (000640) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd., offers business management services. It is a subsidiary of Dong-A Socio Group. It operates in various markets

USD 250 View Report

Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review

Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review

Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Dong-A Socio Holdings Co Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Dong-A Socio Holdings Co Ltd Company Profile is a detailed strategic and analytical report on Dong-A Socio Holdings Co Ltd. The 2018 version of the report offers detailed insights into

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available